Astrazeneca Shs Sponsored American Deposit Receipt Repr 1 Sh $74.72

up +0.56


19/9/2014 04:00 PM  |  NYSE : AZN  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get AZN Trend Analysis - it has outperformed the S&P 500 by 27%

Partner Headlines

  1. Drug giants target Alzheimer's

    IBD
  2. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD
  3. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD
  4. Teva Announces UK High Court Gives Positive Judgment In The Company's Patent ...

    Benzinga
  5. SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC 'Highly Likely'

    Benzinga
  6. AstraZeneca

    IBD
  7. Deutsche Bank Says Pfizer Has A Strong Financial Position And Attractive ...

    Benzinga
  8. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  9. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD
  10. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga
  11. Illumina lines up key partners

    IBD
  12. Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole

    Benzinga
  13. Illumina Forms Partnerships With Big Pharma Firms

    IBD
  14. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga
  15. Stocks Open Higher, Turn Mixed; Illumina Rises, Autohome Slips

    IBD
  16. Treasury Develolping Options to Curb Inversions

    FoxBusiness
  17. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD
  18. Drugmaker AstraZeneca Returns To Growth

    IBD
  19. Walgreen Names New CFO Ahead of Possible Inversion

    IBD
  20. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  21. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  22. Citigroup Comments On Potential Pfizer/AstraZeneca Acquisition

    Benzinga
  23. Merck, Pfizer Beat Q2 Earnings Estimates

    IBD
  24. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  25. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD
  26. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  27. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness
  28. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  29. I Believe AstraZeneca Is Fairly Valued

    GuruFocus
  30. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  31. British Blue Chips Beckon

    Benzinga
  32. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  33. In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK

    FoxBusiness
  34. Dow Trades Above 17,000 While S&P 500 Inches Closer To 2,000

    Benzinga
  35. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  36. S&P: Cut Corporate Taxes to Create 10M New Jobs

    FoxBusiness
  37. Rumor Of Massive Monsanto-Syngenta Deal Gets Agriculture Sector Moving

    Benzinga
  38. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  39. Global M&A Up 73% To $1.6 Trillion; Health, Media Top

    IBD
  40. Medtronic to Buy Covidien for $42.0 Billion

    FoxBusiness
  41. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  42. Morning Market Movers

    Benzinga
  43. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  44. ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects

    Benzinga
  45. M&A Activity Fearless Against Rate Hikes

    FoxBusiness
  46. AstraZeneca sees deal hurdles

    IBD
  47. A Bitter Pill

    FoxBusiness
  48. UPDATE: Ligand Signs Research and Licensing Agreement with Omthera Pharmaceuticals ...

    Benzinga
  49. Allergan May Get Higher Bid

    IBD
  50. Market Wrap For May 13: Markets Close Again At Record Highs

    Benzinga
Trading Center